Longeveron 2024 revenue jumps 237%, eyes FDA approval for Lomecel-B
Longeveron Inc., a biotechnology company specializing in regenerative medicine, has reported significant financial progress alongside major advancements in its investigational stem cell therapy, Lomecel-B. The ... Read More
Regenerative medicine firm Organogenesis stock skyrockets 73% after surprise Q4 profit
Organogenesis Holdings Inc., a leading player in regenerative medicine, has reported a fourth-quarter profit that significantly exceeded market expectations, leading to a dramatic surge in ... Read More
City of Hope researchers unveil thymus regeneration therapy for immune system repair
Scientists at City of Hope, one of the most renowned cancer research and treatment institutions in the United States, have uncovered a novel method to ... Read More
The potential of stem cells: Understanding their role and latest research
Stem cells, often referred to as the building blocks of life, are unspecialised cells capable of developing into various specialised cell types. This remarkable characteristic ... Read More
Scientists discover how salamanders could hold the key to human regeneration
Regeneration has captivated the human imagination for centuries, often depicted in folklore and science fiction. While this remarkable ability is a natural phenomenon in certain ... Read More
Game-changing bone marrow kit from SurGenTec gets FDA approval—find out why it’s a big deal
In a significant leap forward for orthopedic and spine technology, SurGenTec, a leading medical device company, has secured 510(k) clearance from the U.S. Food and ... Read More
Revolutionary nerve healing discovered! How your gums could restore your face
At Penn Dental Medicine, Dr. Ahn Le, the Norman Vine Endowed Professor of Oral Rehabilitation, is leading a groundbreaking approach to nerve repair in the ... Read More
ENCell announces promising results from Phase 1 CMT1A trial of EN001
ENCell Co., Ltd., a South Korean biotech leader specializing in Cell and Gene Therapy (CGT), has unveiled promising results from their first-in-human Phase 1 clinical ... Read More
Oncocross and JW Pharmaceutical forge new path in AI-driven drug development
In a significant stride toward revolutionizing drug discovery and development, Seoul-based biotech firm Oncocross announced on May 22nd a renewed joint research agreement with JW ... Read More
Cynata Therapeutics wraps up patient enrollment for diabetic foot ulcers clinical trial
In a significant development for diabetic foot ulcer treatments, Cynata Therapeutics Limited (ASX: CYP), a leading clinical-stage biotechnology company, has announced the completion of patient ... Read More